mrna elliott wave analysiswhen the majority turns bullish, that is when i always go short.
inverse the majority, and you will usually make away with the loot.
this is a very high risk short setup, for a blow off top on this move.
downside target is around $240, but it could easily only get to $265 before continuation to the upside.
smaller sized play.
good luck!
MRNA
In search for the next BNTX, MRNA and NVAX !!Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem.
And the gains in vaccines stock are quite similar to cryptocurrencies year over year.
From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX 66X.
My question for you is the following: which is the next vaccine developer to make at least 10X our money?? I`m looking forward to discover with you the next big vaccine developer!
And i have a presumption or two which i already shared in my group. And those were the fundamentals i was searching for: data submitted to FDA for Emergency Use Authorization, Phase 3, low Market cap - under 1Bil, on the lower end of 52 Week Range, other drugs in the pipeline, high intraday volume.
Sunday Prep 7/18 - $MRNA SHORTThis is my main focus heading into Monday. It’s getting to be A+ up here. You can see it did a very similar move back in late November of last year. But if this is a repeat of that, then we would need a gap up Monday morning and that would have to hold up and gap 1 last time on Tuesday. Definitely no guarantees that is what is setting up. But I am definitely praying for the gap up tomorrow on this. If we get that, then I will be stalking for lower highs to set in and present some levels to have defined risk against. Remember, if/when this plays out, the downside is NOT just a few points. We are looking for 10,15, even 20pts of downside. If we don’t get the gap up, I will still be interested, but it won’t really be A+ at that point. We NEED this to stay extreme in order to have that big edge.
MRNA target 300Moderna has proven technological advantages of mRNA technology over conventional methods for treatment and vaccination.
with high volume of in pipeline products lead by moderna vaccine for covid19, the valuation of company is bound to grow with Healthcare being the theme for investment.
Moderna NASDAQ: MRNAI only ever got a few entries onto this position early on and have taken profit along the way mainly due to freaking me out with the volatility when we started spiking to 200 dollars back at the end of 2020.
I chose to play some of the bio tech and pharma plays during early covid as a defensive play but also some high risk as the controversy around the vaccines could have significantly back fire on me but I took the punt anyway.
As I mentioned I havent taken any new entries since jan 2021 and just riding what i have left now, but its one of those stocks that just keeps running for me with regret of not going in heavier or not taking profit early with partial position lol but thats the game isnt it, hindsight's a bitch.
Not doing any fancy TA on this, simply just following the channels up and looking for reaction on the outer limit of the pitchfork (set to 1.618) any major break down of the mean and I may look for a top up but I feel its gone far enough and actually looking to de-risk soon and reduce position further.
Probably going to bite me in ass here
OCGN "variant stew"Alot going on in this chart but bear(or bull) with me.. 100MA being tested, broke above trend line and alot of confluence occuring all at once while the "Variant" is the big talk of the days.
Quite a bit of upside here if good PR comes out on OCGN. Otherwise we could see this get swatted right back down under the trend line and below the 100MA. My calls are in for a solid risk reward play here.
Trade safe and have fun! SMASH that like button and let me know your thoughts in the comments!
MRNA - short (now), long (long-term)3 days in a row it is closing lower.
Profit taking may send MRNA to test previous resistance, which now may become a support level.
If all goes well, it should bounce off of 185, or a bit lower within BUY1 zone, and head to ATH in 250’s.
However, we may as well see a bigger sell off, like witnessed 2 times already back in Dec and Feb.
If that happens, MRNA may loose almost all of its gains of the last wave and head to 140’s-150’s, where BUY2 zone is indicated.
I do not expect it to drop more than that, unless there are any bad news (then it can test even lower support levels).
And after that, before or after the next earnings, we shall see ATH in 250’s.
MRNA to ATHlong-awaited reversal brought MRNA to previous highs.
I expect it to go the green way, reaching 220’s-240’s, after which the profit-taking spree will bring it back to 180’s or lower.
much, of course, will depend on the earnings in 2 days.
if the earnings are exceptionally great, it may take the grey way, with potential ATH just shy of 300.
and if they upset, we will see steep decline to 105-120’s support.
Moderna Inc. stock - "The end of a pandemic Stock" Moderna, a drugmaker with just a single product to its name
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
Triple Top in MODERNAThose who have early access to my trading ideas have the chance to perform better.
Don't you believe it?
Check my recently private post:
Road Map for next week earning call!
If you have the stock better have a tight stop loss or exit plan!
watch the stock closely for the short opportunity, since the market did not respond well to earning reports in the last 2 weeks!
Evaluate the possible scenarios:
1- What Is a Triple Top?
A triple top is formed by three peaks moving into the same area, with pullbacks in between.
A triple top is considered complete, indicating a further price slide, once the price moves below pattern support.
A trader exits longs or enters shorts when the triple top completes.
If trading the pattern, a stop loss can be placed above resistance (peaks).
The estimated downside target for the pattern is the height of the pattern subtracted from the breakout point.
www.investopedia.com
2-What Are Three Inside Up/Down?
Three inside up and three inside down are three-candle reversal patterns that appear on candlestick charts. The pattern requires three candles to form in a specific sequence, showing that the current trend has lost momentum and a move in the other direction might be starting.
www.investopedia.com
3-Trading value!
When prices reach new highs (or no lows) on decreasing volume , watch out; a reversal might be taking shape.
The constant decrease in trading value from 9.5 billion to 1.5 billion in the last 4 months.
www.investopedia.com
4- Bearish harmonic pattern
www.investopedia.com
If you are interested to have early access to my trading ideas, check the signature box below the post for more information.
Will we finally see 200+?My analysis for MRNA
On May 3rd or 4th, breakout is expected
- Flag marked with thick purple lines.
- Triangle marked with upper thick purple line and lower green line
- Diamond (marked in green dotted lines) should drive stock into the zone marked with small purple box.
- Breakout may happen at the top right corner of the purple box. It may also break out hours (maybe a day) after, and if it does, it may move according to the green arrows.
- Stock should reach top of grey box before May 10th, further analysis to be done after hitting the top.
I'm not a financial advisor. Follow my advice at your own risk.
MRNA & end of the bulls?MRNA has had a few wild weeks going up from $120 to $170.
I believe this could be the end of the bullishness and it may do a correction.
Why do I believe this could happen?
MRNA hit historic resistance of $170, after hitting that mark it began dropping. This resistance seems like it can hold.
RSI is bounced off the 70 mark on the daily chart.
RSI is overbought on the 4HR chart
EMA's are beginning to cross over on the hour charts.
This could be a tiny correction and just bounce off $160 before continuing its path to $200 so I would keep a close eye on the stock.
What I am looking for right now is:
1st support - $160
2nd support - $139_$145
3rd support - $120
At this point MRNA going back down to $100 or even lower seems incredibly unlikely.
Moderna's earnings arent too far away so that could act as a catalyzer that will continue the growth.
In short I believe that MRNA could have hit the resistance and it will either go down to the listed supports or if it stays in these levels then it will most likely stay like this till earnings come which will tell what direction it is going to go from here.
Please comment down your ideas and thoughts on this, I would appreciate any criticism you may have on the charts and analysis, and looking forward to your comments!
I am not a financial advisor, these are my personal ideas an thoughts please do your own research before buying a stock.
Biotech Double Bottom (+ Divergence & Bollinger Reversal)Technical Analysis
1. As you see in the chart, we have tested the 200ema 3 times in the past; and it has not trade below it since April 2020.
We have made a spinning-bottom on a downtrend, coincidental with a 4th test of the 200ema.
2. RSI and OBV show a positive divergence as the bottom from 2 weeks ago (Test #3) was at a lower level.
3. Bollinger Bands give us another bullish signal, as the first low (Test #3) was outside the lower BB, and the second low (Test #4) was inside the lower BB.
Trade Setup
A break below Test #3 which is $142.47 could be a potentially good place to set a stop-loss exit.
Short-term target to the upside --> $160.5
Mid-term target to the upside --> $170
Trade with care
Bullish trendPfizer Inc.
Pfizer Inc. - PFE has a BULLISH trend
Argus
Outlook:Bullish
Long Term Target:55.00
Current Price:37.16
Idea Generated at:Apr 13, 2021
As JNJ struggles more will rotate to PFE
Reaffirming BUY with $55 target
Pfizer is scaling up manufacturing to meet its commitment to deliver two billion doses of its coronavirus vaccine by the end of 2021.